Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Mallinckrodt
Medtronic
Boehringer Ingelheim
Colorcon

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for (EPP)Self Insured Schools of California v. Merck and Co Inc (E.D. Va. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

(EPP)Self Insured Schools of California v. Merck and Co Inc (E.D. Va. 2018)

Docket   Start Trial Date Filed 2018-06-21
Court District Court, E.D. Virginia Date Terminated 2019-05-07
Cause 15:1 Antitrust Litigation Assigned To Rebecca Beach Smith
Jury Demand Plaintiff Referred To Douglas E. Miller
Parties GLENMARK GENERICS INC., U.S.A.; GLENMARK PHARMACEUTICALS LTD.; MERCK AND CO., INC.; MERCK SHARP AND DOHME CORP.; MSP SINGAPORE CO. LLC; PAR PHARMACEUTICAL, INC.; SCHERING CORP.; SCHERING-PLOUGH CORP.; SELF INSURED SCHOOLS OF CALIFORNIA
Patents 7,030,106; 7,612,058; RE37,721
Attorneys Amanda L. Czocher; Bryan A Merryman; Christopher D. Dusseault; Conrad Moss Shumadine; Eric C Grannon; Joseph R Saveri; Kyla Gibboney; Michael Minshen Lee; Nicomedes Sy Herrera; Ryan J McEwan; Samuel G. Liversidge; Sujal Shah; V Chai Oliver Prentice
Firms Gibson Dunn & Crutcher; Joseph Saveri Law Firm, Inc.; White and Case; White and Case LLP
Link to Docket External link to docket
Small Molecule Drugs cited in (EPP)Self Insured Schools of California v. Merck and Co Inc
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for (EPP)Self Insured Schools of California v. Merck and Co Inc (E.D. Va. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 issued as U.S. 4 Patent No. 7,030,106. According to Merck, the ’106 patent originally was set to …U.S. Patent No. 5,631,365 (“the ’365 15 patent”), U.S. Patent No. 5,767,115 (“the ’115 patent”), U.S… U.S. Patent No. 5,846,966 16 (“the ’966 patent”), the RE’721 reissue patent, and the RE’461 reissue… U.S. Patent No. 5,631,365. The ’365 patent was the first-issued 19 Merck azetidinone patent. The …. On May 28, 2002, the Patent 2 Office re-issued the patent as U.S. Patent No. RE37,721. 3 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Express Scripts
Dow
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.